Paper32389751
Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration.
Wei H and 3 others. Neuropharmacology, 2020. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration. Papers, record 32389751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32389751
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cebranopadol reduces cocaine self-administration in male rats: Dose, treatment and safety consideration.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Analgesics, Opioid | Major topic |
| Cocaine-Related Disorders | Major topic |
| Indoles | Major topic |
| Spiro Compounds | Major topic |
| Animals | |
| Conditioning, Operant | |
| Dose-Response Relationship, Drug | |
| Heroin | |
| Male | |
| Rats | |
| Rats, Sprague-Dawley | |
| Reinforcement Schedule | |
| Self Administration |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UH2 DA041115 | NIDA NIH HHS | United States | UH2DA041115 | PubMed and NIH | NIH RePORTER |
| R01 DA035552 | NIDA NIH HHS | United States | R01DA035552 | PubMed and NIH | NIH RePORTER |
| R01 DA025100 | NIDA NIH HHS | United States | R01DA025100 | PubMed and NIH | NIH RePORTER |
| R01 DA032910 | NIDA NIH HHS | United States | R01DA032910 | PubMed and NIH | NIH RePORTER |
| UH3 DA041115 | NIDA NIH HHS | United States | UH2DA041115 | PubMed and NIH | NIH RePORTER |
| U18 DA052319 | NIDA NIH HHS | United States | U18DA052319 | PubMed | NIH RePORTER |
| U01 DA051079 | NIDA NIH HHS | United States | U01DA051079 | PubMed | NIH RePORTER |
| R01 DA013930 | NIDA NIH HHS | United States | R01DA013930 | PubMed and NIH | NIH RePORTER |
| UH3DA041115 | NIH | NIH RePORTER |
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20,161,378 | Recent progress in protein drug design and discovery with a focus on novel approaches to the development of anti-cocaine medications. | Future Med Chem | 2009 | https://conductscience.org/library/papers/20161378 | PubMed |
| 2 | 31,499,241 | In vivo characterization of toxicity of norcocaethylene and norcocaine identified as the most toxic cocaine metabolites in male mice. | Drug Alcohol Depend | 2019 | https://conductscience.org/library/papers/31499241 | PubMed |
| 3 | 14,624,331 | Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats. | Psychopharmacology (Berl) | 2004 | https://conductscience.org/library/papers/14624331 | PubMed |
| 5 | 31,152,783 | Cebranopadol, a Novel First-in-Class Analgesic Drug Candidate: First Experience With Cancer-Related Pain for up to 26 Weeks. | J Pain Symptom Manage | 2019 | https://conductscience.org/library/papers/31152783 | PubMed |
| 6 | 29,180,970 | Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors. | Front Psychiatry | 2017 | https://conductscience.org/library/papers/29180970 | PubMed |
| 7 | 30,080,993 | Kinetic characterization of cholinesterases and a therapeutically valuable cocaine hydrolase for their catalytic activities against heroin and its metabolite 6-monoacetylmorphine. | Chem Biol Interact | 2018 | https://conductscience.org/library/papers/30080993 | PubMed |
| 8 | 22,300,091 | Are pharmacokinetic approaches feasible for treatment of cocaine addiction and overdose? | Future Med Chem | 2012 | https://conductscience.org/library/papers/22300091 | PubMed |
| 9 | 21,371,010 | Predictive validity of behavioural animal models for chronic pain. | Br J Pharmacol | 2011 | https://conductscience.org/library/papers/21371010 | PubMed |
| 10 | 19,474,215 | Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile. | Br J Anaesth | 2009 | https://conductscience.org/library/papers/19474215 | PubMed |
| 11 | 17,522,627 | Endogenous nociceptin (orphanin FQ) suppresses basal hedonic state and acute reward responses to methamphetamine and ethanol, but facilitates chronic responses. | Neuropsychopharmacology | 2008 | https://conductscience.org/library/papers/17522627 | PubMed |
| 12 | 21,481,103 | Pharmacokinetic modeling of subcutaneous heroin and its metabolites in blood and brain of mice. | Addict Biol | 2013 | https://conductscience.org/library/papers/21481103 | PubMed |
| 13 | 29,127,295 | Clinical Potential of an Enzyme-based Novel Therapy for Cocaine Overdose. | Sci Rep | 2017 | https://conductscience.org/library/papers/29127295 | PubMed |
| 14 | 8,555,282 | Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence. | J Addict Dis | 1995 | https://conductscience.org/library/papers/8555282 | PubMed |
| 15 | 17,475,739 | A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial. | Am J Psychiatry | 2007 | https://conductscience.org/library/papers/17475739 | PubMed |
| 16 | 31,010,646 | Hot topics in opioid pharmacology: mixed and biased opioids. | Br J Anaesth | 2019 | https://conductscience.org/library/papers/31010646 | PubMed |
| 17 | 8,163,014 | cDNA cloning and regional distribution of a novel member of the opioid receptor family. | FEBS Lett | 1994 | https://conductscience.org/library/papers/8163014 | PubMed |
| 18 | 30,531,478 | Assessment of the Abuse Potential of Cebranopadol in Nondependent Recreational Opioid Users: A Phase 1 Randomized Controlled Study. | J Clin Psychopharmacol | 2019 | https://conductscience.org/library/papers/30531478 | PubMed |
| 19 | 11,710,090 | Definition of and mechanism for opioid-induced sedation. | Pain Manag Nurs | 2001 | https://conductscience.org/library/papers/11710090 | PubMed |
| 20 | 25,677,778 | Nociceptin/orphanin-FQ modulation of learning and memory. | Vitam Horm | 2015 | https://conductscience.org/library/papers/25677778 | PubMed |
| 21 | 24,680,219 | Abuse and diversion of buprenorphine sublingual tablets and film. | J Subst Abuse Treat | 2014 | https://conductscience.org/library/papers/24680219 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,515,800 | Preclinical Evaluation of Dual NOP/Mu Partial Agonists for Methamphetamine Use Disorder. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515800 | PubMed |
| 41,465,239 | Effects of Fentanyl-Adulterated Methamphetamine on Circulating Ghrelin in Rats. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41465239 | PubMed |
| 40,969,879 | Development of a Ghrelin Deacylase to Attenuate Drug Reward and Associated Effects of Methamphetamine. | ACS Pharmacol Transl Sci | 2025 | https://conductscience.org/library/papers/40969879 | PubMed |
| 40,076,960 | Effects of Fentanyl-Laced Cocaine on Circulating Ghrelin, Insulin, and Glucose Levels in Rats. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076960 | PubMed |
| 39,146,775 | A quantitative LC-MS/MS method for investigation of polysubstance use involving heroin and cocaine. | J Pharm Biomed Anal | 2024 | https://conductscience.org/library/papers/39146775 | PubMed |
| 38,740,850 | In vitro and in vivo stability of a highly efficient long-acting cocaine hydrolase. | Sci Rep | 2024 | https://conductscience.org/library/papers/38740850 | PubMed |
| 38,256,863 | Novel Opioids in the Setting of Acute Postoperative Pain: A Narrative Review. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38256863 | PubMed |
| 38,195,724 | Long-lasting blocking of interoceptive effects of cocaine by a highly efficient cocaine hydrolase in rats. | Sci Rep | 2024 | https://conductscience.org/library/papers/38195724 | PubMed |
| 36,635,293 | Catalytic activities of a highly efficient cocaine hydrolase for hydrolysis of biologically active cocaine metabolites norcocaine and benzoylecgonine. | Sci Rep | 2023 | https://conductscience.org/library/papers/36635293 | PubMed |
| 32,710,979 | Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine. | Neuropharmacology | 2020 | https://conductscience.org/library/papers/32710979 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| OPRK1 | 4,986 | PubTator's text mining | https://conductscience.org/library/genes/4986 | NCBI Gene |
| OPRL1 | 4,987 | PubTator's text mining | https://conductscience.org/library/genes/4987 | NCBI Gene |
| OPRM1 | 4,988 | PubTator's text mining | https://conductscience.org/library/genes/4988 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32389751
GET https://conductscience.org/api/papers/v1/32389751/references?page=2